• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型 ingenol 衍生物对急性和潜伏 HIV-1 感染的双重作用。

Dual effects of the novel ingenol derivatives on the acute and latent HIV-1 infections.

机构信息

State Key Laboratory of Genetic Engineering and Engineering Research Center of Gene Technology, Ministry of Education, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai, 200438, China.

Department of Infectious Diseases, Key Laboratory of Medical Molecular Virology of Ministry of Education/Health, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.

出版信息

Antiviral Res. 2019 Sep;169:104555. doi: 10.1016/j.antiviral.2019.104555. Epub 2019 Jul 9.

DOI:10.1016/j.antiviral.2019.104555
PMID:31295520
Abstract

The latent reservoir of HIV-1 in resting memory CD4 T cells serves as a major barrier to curing HIV-1 infection. Reactivation of latent HIV-1 is proposed as a promising strategy for the clearance of the viral reservoirs. Because of the limitations of current latency reversal agents (LRAs), identification of new LRAs is urgently required. Here, we analyzed Euphorbia kansui extracts and obtained three ingenol derivative compounds named EK-1A, EK-5A and EK-15A. We found that ingenol derivatives can effectively reactivate latent HIV-1 at very low (nanomolar) concentrations in HIV latency model in vitro. Furthermore, ingenol derivatives exhibited synergy with other LRAs in reactivating latent HIV-1. We verified that EK-15A can promote latent HIV-1 reactivation in the ex vivo resting CD4 T cells isolated from the peripheral blood of HIV-infected individuals on suppressive antiretroviral therapy. In addition, ingenol derivatives down-regulated the expression of cell surface HIV co-receptors CCR5 and CXCR4, therefore potentially preventing new infection of HIV-1. Our results indicated that the ingenol derivatives extracted from Euphorbia kansui have dual functions: reactivation of latent HIV-1 and inhibition of HIV-1 infection.

摘要

HIV-1 潜伏在静止记忆 CD4 T 细胞中的储库是治愈 HIV-1 感染的主要障碍。潜伏 HIV-1 的激活被提出作为清除病毒储库的一种有前途的策略。由于当前潜伏逆转剂 (LRA) 的局限性,迫切需要鉴定新的 LRA。在这里,我们分析了大戟属植物甘遂的提取物,得到了三种 10-去乙酰巴卡丁 III 衍生物化合物,分别命名为 EK-1A、EK-5A 和 EK-15A。我们发现,在体外 HIV 潜伏模型中,这些 10-去乙酰巴卡丁 III 衍生物化合物可以在非常低(纳摩尔)浓度下有效激活潜伏的 HIV-1。此外,10-去乙酰巴卡丁 III 衍生物化合物在激活潜伏 HIV-1 方面表现出与其他 LRA 的协同作用。我们验证了 EK-15A 可以促进抑制性抗逆转录病毒治疗的 HIV 感染者外周血分离的静止 CD4 T 细胞中潜伏 HIV-1 的重新激活。此外,10-去乙酰巴卡丁 III 衍生物化合物下调了细胞表面 HIV 共受体 CCR5 和 CXCR4 的表达,因此可能预防 HIV-1 的新感染。我们的研究结果表明,从甘遂中提取的 10-去乙酰巴卡丁 III 衍生物具有双重功能:激活潜伏的 HIV-1 和抑制 HIV-1 感染。

相似文献

1
Dual effects of the novel ingenol derivatives on the acute and latent HIV-1 infections.新型 ingenol 衍生物对急性和潜伏 HIV-1 感染的双重作用。
Antiviral Res. 2019 Sep;169:104555. doi: 10.1016/j.antiviral.2019.104555. Epub 2019 Jul 9.
2
Reactivation of HIV-1 from Latency by an Ingenol Derivative from Euphorbia Kansui.甘遂醇衍生物通过使潜伏状态的 HIV-1 重新激活。
Sci Rep. 2017 Aug 25;7(1):9451. doi: 10.1038/s41598-017-07157-0.
3
Dual role of novel ingenol derivatives from Euphorbia tirucalli in HIV replication: inhibition of de novo infection and activation of viral LTR.来自麻风树的新型大戟醇衍生物在HIV复制中的双重作用:抑制从头感染和激活病毒长末端重复序列
PLoS One. 2014 May 14;9(5):e97257. doi: 10.1371/journal.pone.0097257. eCollection 2014.
4
Euphorbia Kansui Reactivates Latent HIV.甘遂可重新激活潜伏的艾滋病毒。
PLoS One. 2016 Dec 15;11(12):e0168027. doi: 10.1371/journal.pone.0168027. eCollection 2016.
5
Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic Patients.来自无病毒血症患者静息CD4(+) T细胞中,二苯甲酸 Ingenol 和帕比司他的体外生物活性及HIV-1潜伏逆转作用
Antimicrob Agents Chemother. 2015 Oct;59(10):5984-91. doi: 10.1128/AAC.01077-15. Epub 2015 Jul 13.
6
4-Deoxyphorbol inhibits HIV-1 infection in synergism with antiretroviral drugs and reactivates viral reservoirs through PKC/MEK activation synergizing with vorinostat.4-去氧胆酸抑制 HIV-1 感染与抗逆转录病毒药物协同作用,并通过与伏立诺他协同激活 PKC/MEK 来重新激活病毒储存库。
Biochem Pharmacol. 2020 Jul;177:113937. doi: 10.1016/j.bcp.2020.113937. Epub 2020 Mar 26.
7
Effective in vivo reactivation of HIV-1 latency reservoir via oral administration of EK-16A-SNEDDS.口服 EK-16A-SNEDDS 可有效激活 HIV-1 潜伏储库。
Eur J Pharm Biopharm. 2024 Aug;201:114353. doi: 10.1016/j.ejpb.2024.114353. Epub 2024 Jun 15.
8
Latency reversal agents affect differently the latent reservoir present in distinct CD4+ T subpopulations.潜伏逆转剂对不同 CD4+ T 亚群中存在的潜伏储库的影响不同。
PLoS Pathog. 2019 Aug 19;15(8):e1007991. doi: 10.1371/journal.ppat.1007991. eCollection 2019 Aug.
9
Compounds producing an effective combinatorial regimen for disruption of HIV-1 latency.产生有效组合方案以破坏 HIV-1 潜伏期的化合物。
EMBO Mol Med. 2018 Feb;10(2):160-174. doi: 10.15252/emmm.201708193.
10
Effects of diterpenes from latex of Euphorbia lactea and Euphorbia laurifolia on human immunodeficiency virus type 1 reactivation.乳浆大戟和飞扬草二萜对人类免疫缺陷病毒 1 型激活的影响。
Phytochemistry. 2010 Feb;71(2-3):243-8. doi: 10.1016/j.phytochem.2009.10.005. Epub 2009 Nov 10.

引用本文的文献

1
Medicinal Chemistry of Anti-HIV-1 Latency Chemotherapeutics: Biotargets, Binding Modes and Structure-Activity Relationship Investigation.抗 HIV-1 潜伏化疗药物的药物化学:生物靶点、结合模式和构效关系研究。
Molecules. 2022 Dec 20;28(1):3. doi: 10.3390/molecules28010003.
2
Impact of IL-15 and latency reversing agent combinations in the reactivation and NK cell-mediated suppression of the HIV reservoir.IL-15 与潜伏逆转剂联合对 HIV 储存库的激活和 NK 细胞介导的抑制作用的影响。
Sci Rep. 2022 Nov 3;12(1):18567. doi: 10.1038/s41598-022-23010-5.
3
EK-16A liposomes enhance HIV replication in ACH2 or J-Lat 10.6 cell engrafted NSG mice.
EK-16A脂质体增强了移植了ACH2或J-Lat 10.6细胞的NSG小鼠体内的HIV复制。
Nanotheranostics. 2022 Mar 21;6(3):325-336. doi: 10.7150/ntno.69259. eCollection 2022.
4
Changes to the Simian Immunodeficiency Virus (SIV) Reservoir and Enhanced SIV-Specific Responses in a Rhesus Macaque Model of Functional Cure after Serial Rounds of Romidepsin Administrations.在经过几轮罗米地辛给药后,恒河猴功能性治愈模型中猴免疫缺陷病毒(SIV)储存库的变化和增强的 SIV 特异性反应。
J Virol. 2022 Jun 22;96(12):e0044522. doi: 10.1128/jvi.00445-22. Epub 2022 May 31.
5
Human Immunodeficiency Virus-1 Latency Reversal the Induction of Early Growth Response Protein 1 to Bypass Protein Kinase C Agonist-Associated Immune Activation.人类免疫缺陷病毒1型潜伏逆转:诱导早期生长反应蛋白1以绕过蛋白激酶C激动剂相关的免疫激活
Front Microbiol. 2022 Mar 10;13:836831. doi: 10.3389/fmicb.2022.836831. eCollection 2022.
6
So Pathogenic or So What?-A Brief Overview of SIV Pathogenesis with an Emphasis on Cure Research.如此致病还是怎样?——重点介绍 SIV 发病机制的简要概述及治愈研究
Viruses. 2022 Jan 12;14(1):135. doi: 10.3390/v14010135.
7
Pharmacological suppression of glycogen synthase kinase-3 reactivates HIV-1 from latency via activating Wnt/β-catenin/TCF1 axis in CD4 T cells.通过激活 CD4 T 细胞中的 Wnt/β-catenin/TCF1 轴,抑制糖原合酶激酶-3 的药理学作用可使潜伏状态的 HIV-1 重新激活。
Emerg Microbes Infect. 2022 Dec;11(1):391-405. doi: 10.1080/22221751.2022.2026198.
8
Combinations of Histone Deacetylase Inhibitors with Distinct Latency Reversing Agents Variably Affect HIV Reactivation and Susceptibility to NK Cell-Mediated Killing of T Cells That Exit Viral Latency.组蛋白去乙酰化酶抑制剂与不同潜伏期逆转剂的组合对HIV再激活以及对退出病毒潜伏期的T细胞的NK细胞介导杀伤敏感性有不同影响。
Int J Mol Sci. 2021 Jun 22;22(13):6654. doi: 10.3390/ijms22136654.
9
Knowledge From London and Berlin: Finding Threads to a Functional HIV Cure.伦敦与柏林的经验:探寻功能性 HIV 治愈方法。
Front Immunol. 2021 May 27;12:688747. doi: 10.3389/fimmu.2021.688747. eCollection 2021.
10
NF-κB sub-pathways and HIV cure: A revisit.NF-κB 亚通路与 HIV 治愈:再探。
EBioMedicine. 2021 Jan;63:103159. doi: 10.1016/j.ebiom.2020.103159. Epub 2020 Dec 16.